Introducing Sanbot Nano, an AI Robot for the Home
Today at IFA 2017, QIHAN Technology Company (QIHAN) introduced Sanbot Nano, a home assistant robot equipped with Amazon’s Alexa Voice Service. Building on QIHAN’s success in delivering “robotics-as-a-service” solutions, the intelligent, cloud-enabled robot features voice capabilities via Alexa, smart home control and remote monitoring capabilities, delivering centralized management and security to households around the world. Sanbot Nano currently supports English and German languages and will available for purchase starting in October for $2,800.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170830005264/en/
QIHAN introduces Sanbot Nano at IFA 2017. (Photo: QIHAN Technology Co. Ltd.)
“The world is captivated by the emergence of robotic developments and we’re constantly challenging ourselves to making the most amazing robot experiences possible,” said Ryan Wu, CMO, QIHAN. “With Sanbot Elf’s breakthrough growth in the retail, hospitality, public service and government industries, we are excited to introduce a robot for the home. Sanbot Nano’s customized capabilities will make every family feel like they have a personal assistant.”
Sanbot Nano stands at 2.7 feet tall and is equipped with over 50 sensors to avoid objects in its way, recognize voices and know when someone enters the room. Sanbot Nano is also equipped with advanced features for the home, including:
- Voice Capabilities: Through Amazon’s Alexa Voice Service, Sanbot Nano can order pizza, request a car, track fitness stats, control the TV, play music from today’s leading streaming providers and more.
- Smart Home Control: Sanbot Nano pairs with smart home devices from the world’s most popular connected home brands, enabling families to control lights, thermostats and home appliances.
- Remote Monitoring: QIHAN’s mobile Q-Link App allows families to live-stream video and control Sanbot Nano from anywhere in the world.
In addition to Sanbot Nano’s new voice capabilities and smart home control features, the new mini robot inherits many popular features from QIHAN’s Sanbot Elf including the Android SDK, Sanbot App Store and automatic charging.
Sanbot Nano demos will be available during IFA 2017, located at the Messe Center - Berlin ExpoCenter City, Hall 7.1A, Booth: 101.
For more information about QIHAN’s Sanbot Nano, please visit: http://en.sanbot.com/nano.html.
About QIHAN Technology Co. Ltd.
Headquartered in Shenzhen, China and founded in 2006, QIHAN Technology Co. Ltd. is a company focused on innovations in robotics, artificial intelligence (AI), and data analysis. Its proprietary solutions, QIHAN Cloud, Sanbot, and Q-Link, utilize next-generation robotics and artificial intelligent (AI) technologies to help improve the lives of its customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170830005264/en/
Contact information
Racepoint Global
Steven Burk
sburk@racepointglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LabPMM ® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 07:30:00 EEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 04:30:00 EEST | Press release
Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contributing to a safe and secure Smart Society. [About Laxton] Laxton develops ID authentication services using biometric information
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 04:20:00 EEST | Press release
Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high function optical film for 65 inch large screen displays. Designed
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 03:27:00 EEST | Press release
Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already ordered. How Payment via AR Glasses Works: Users link their Alipay account via the Rokid app and enable voice verification. In stores, they say: “Rokid, pay 10 RMB.” The glasses scan the merchant’s Alipay QR code. Users confirm by voice, with payment details shown on the display. Advantages of Payment via AR Glasses: Transactions complete in second
SES Successfully Prices €1 Billion Dual-Tranche Bond Offering with Strong 5.5x Oversubscription17.6.2025 23:25:00 EEST | Press release
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), OR TO ANY US PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933), OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. SES S.A. today announced the successful launch and pricing of a dual-tranche note offering in which the company has agreed to sell senior unsecured fixed rate notes under its €5,500,000,000 EMTN Programme (the "Notes"). Settlement is expected to take place on 24 June 2025: EUR 500 million of Notes will bear a coupon of 4.125% due in 2030. EUR 500 million of Notes will bear a coupon of 4.875% due in 2033. SES is rated Baa3, negative outlook by Moody’s and BBB, negative outlook by Fitch. SES shall apply the net proceeds of the Notes towards its general corporate purposes, including, without limitation (i) financ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom